EFFECT OF BODHIVRIKSHAKWATHAPANA IN HIGH BP

Applied Aspect of Bodhivriksha Kwathapana in Essential Hypertensionâ??A Pilot Study

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/05/008557

Enrollment

Registered

2017-05-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- High Blood pressure

Interventions

Intervention1: Bodhivriksha Kwathpana: Dose- 40 ml twice a day empty stomach route of administration- oral

Eligibility

Inclusion criteria

Inclusion criteria: Having Bp more than 130/90 mmHg with no sign and symptoms

Exclusion criteria

Exclusion criteria: Malignant Hypertension when BP more than 180/110 mmHg associated with other system

Design outcomes

Primary

Measure	Time frame
To Evaluate the Effect of Bodhivrikshakwathapana in Essential HypertensionTimepoint: in 2 months	—

Secondary

Measure	Time frame
Exacerbation of sign and symptomsTimepoint: 15 days	—

Countries

India

Contacts

Public ContactDr Nidhi Chaudhary

Rishikul Campus, Uttarakhand Ayurved University

Virgo.alok@gmail.com9045087121

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026